Omnicell Statistics
Total Valuation
Omnicell has a market cap or net worth of $1.20 billion. The enterprise value is $1.29 billion.
| Market Cap | 1.20B |
| Enterprise Value | 1.29B |
Important Dates
The next estimated earnings date is Tuesday, July 30, 2024, after market close.
| Earnings Date | Jul 30, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Omnicell has 45.92 million shares outstanding. The number of shares has increased by 1.88% in one year.
| Shares Outstanding | 45.92M |
| Shares Change (YoY) | +1.88% |
| Shares Change (QoQ) | +0.52% |
| Owned by Insiders (%) | 1.58% |
| Owned by Institutions (%) | 102.91% |
| Float | 42.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 18.98 |
| PS Ratio | 1.09 |
| Forward PS | 1.08 |
| PB Ratio | 1.01 |
| P/FCF Ratio | 7.30 |
| PEG Ratio | 2.28 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.29, with an EV/FCF ratio of 7.86.
| EV / Earnings | n/a |
| EV / Sales | 1.17 |
| EV / EBITDA | 21.29 |
| EV / EBIT | n/a |
| EV / FCF | 7.86 |
Financial Position
The company has a current ratio of 2.38, with a Debt / Equity ratio of 0.51.
| Current Ratio | 2.38 |
| Quick Ratio | 1.83 |
| Debt / Equity | 0.51 |
| Debt / EBITDA | 9.96 |
| Debt / FCF | 3.68 |
| Interest Coverage | 1.99 |
Financial Efficiency
Return on equity (ROE) is -1.80% and return on invested capital (ROIC) is -1.88%.
| Return on Equity (ROE) | -1.80% |
| Return on Assets (ROA) | -0.90% |
| Return on Capital (ROIC) | -1.88% |
| Revenue Per Employee | $302,092 |
| Profits Per Employee | -$5,766 |
| Employee Count | 3,650 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 5.22 |
Taxes
In the past 12 months, Omnicell has paid $4.29 million in taxes.
| Income Tax | 4.29M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -64.14% in the last 52 weeks. The beta is 0.84, so Omnicell's price volatility has been lower than the market average.
| Beta (5Y) | 0.84 |
| 52-Week Price Change | -64.14% |
| 50-Day Moving Average | 29.30 |
| 200-Day Moving Average | 32.96 |
| Relative Strength Index (RSI) | 34.97 |
| Average Volume (20 Days) | 575,340 |
Short Selling Information
The latest short interest is 1.96 million, so 4.26% of the outstanding shares have been sold short.
| Short Interest | 1.96M |
| Short Previous Month | 1.96M |
| Short % of Shares Out | 4.26% |
| Short % of Float | 4.58% |
| Short Ratio (days to cover) | 5.07 |
Income Statement
In the last 12 months, Omnicell had revenue of $1.10 billion and -$21.05 million in losses. Loss per share was -$0.46.
| Revenue | 1.10B |
| Gross Profit | 464.43M |
| Operating Income | -33.75M |
| Pretax Income | -16.76M |
| Net Income | -21.05M |
| EBITDA | 60.77M |
| EBIT | -33.75M |
| Loss Per Share | -$0.46 |
Balance Sheet
The company has $512.36 million in cash and $605.01 million in debt, giving a net cash position of -$92.64 million or -$2.02 per share.
| Cash & Cash Equivalents | 512.36M |
| Total Debt | 605.01M |
| Net Cash | -92.64M |
| Net Cash Per Share | -$2.02 |
| Equity (Book Value) | 1.19B |
| Book Value Per Share | 25.88 |
| Working Capital | 573.55M |
Cash Flow
In the last 12 months, operating cash flow was $218.28 million and capital expenditures -$53.72 million, giving a free cash flow of $164.56 million.
| Operating Cash Flow | 218.28M |
| Capital Expenditures | -53.72M |
| Free Cash Flow | 164.56M |
| FCF Per Share | $3.60 |
Margins
Gross margin is 42.12%, with operating and profit margins of -3.06% and -1.91%.
| Gross Margin | 42.12% |
| Operating Margin | -3.06% |
| Pretax Margin | -1.52% |
| Profit Margin | -1.91% |
| EBITDA Margin | 5.51% |
| EBIT Margin | -3.06% |
| FCF Margin | 14.92% |
Dividends & Yields
Omnicell does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.88% |
| Shareholder Yield | -1.88% |
| Earnings Yield | -1.75% |
| FCF Yield | 13.70% |
Analyst Forecast
The average price target for Omnicell is $43.25, which is 65.33% higher than the current price. The consensus rating is "Buy".
| Price Target | $43.25 |
| Price Target Difference | 65.33% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 10.86% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Omnicell has an Altman Z-Score of 1.61 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.61 |
| Piotroski F-Score | 3 |